Published in Structure on January 13, 2010
Cellular strategies for regulating DNA supercoiling: a single-molecule perspective. Cell (2010) 1.25
Requirements for catalysis in the Cre recombinase active site. Nucleic Acids Res (2010) 0.98
Crystal structure of a bacterial topoisomerase IB in complex with DNA reveals a secondary DNA binding site. Structure (2010) 0.89
Mechanism and specificity of DNA strand exchange catalyzed by vaccinia DNA topoisomerase type I. Biochemistry (2010) 0.82
Variola type IB DNA topoisomerase: DNA binding and supercoil unwinding using engineered DNA minicircles. Biochemistry (2014) 0.81
Biochemical characterization of the topoisomerase domain of Methanopyrus kandleri topoisomerase V. J Biol Chem (2014) 0.77
Chemical mutagenesis of vaccinia DNA topoisomerase lysine 167 provides insights to the catalysis of DNA transesterification. Biochemistry (2013) 0.77
Diverse energetic effects of charge reversal mutations of poxvirus topoisomerase IB. Biochemistry (2012) 0.76
Topoisomerase IB-DNA interactions: X marks the spot. Structure (2010) 0.76
Stereospecific suppression of active site mutants by methylphosphonate substituted substrates reveals the stereochemical course of site-specific DNA recombination. Nucleic Acids Res (2015) 0.75
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem (2001) 12.53
DNA topoisomerases. Annu Rev Biochem (1996) 9.48
Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science (1998) 4.51
Mechanisms of site-specific recombination. Annu Rev Biochem (2006) 4.29
A model for the mechanism of human topoisomerase I. Science (1998) 4.10
DNA bending: the prevalence of kinkiness and the virtues of normality. Nucleic Acids Res (1998) 3.67
Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB. Nature (2005) 2.91
Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol (1991) 2.59
Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases. Cell (1998) 2.40
Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I. J Biol Chem (1990) 1.83
C-H...O hydrogen bonding in biology. Trends Biochem Sci (1997) 1.76
Mechanistic plasticity of DNA topoisomerase IB: phosphate electrostatics dictate the need for a catalytic arginine. Structure (2005) 1.74
Catalytic mechanism of DNA topoisomerase IB. Mol Cell (2000) 1.61
Conformations of the sugar-phosphate backbone in helical DNA crystal structures. Biopolymers (1997) 1.53
Human DNA topoisomerase I: relaxation, roles, and damage control. Chromosoma (2005) 1.51
Vaccinia virus DNA topoisomerase: a model eukaryotic type IB enzyme. Biochim Biophys Acta (1998) 1.46
A role for CH...O interactions in protein-DNA recognition. J Mol Biol (1998) 1.36
Vaccinia DNA topoisomerase I: evidence supporting a free rotation mechanism for DNA supercoil relaxation. Biochemistry (1997) 1.35
Structural basis for specificity in the poxvirus topoisomerase. Mol Cell (2006) 1.34
The power of vanadate in crystallographic investigations of phosphoryl transfer enzymes. FEBS Lett (2004) 1.32
A poxvirus-like type IB topoisomerase family in bacteria. Proc Natl Acad Sci U S A (2002) 1.31
Site-specific interaction of vaccinia virus topoisomerase I with duplex DNA. Minimal DNA substrate for strand cleavage in vitro. J Biol Chem (1991) 1.31
Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry (2000) 1.27
Proton relay mechanism of general acid catalysis by DNA topoisomerase IB. J Biol Chem (2001) 1.15
The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA. J Mol Biol (2006) 1.14
Synapsis of loxP sites by Cre recombinase. J Biol Chem (2007) 1.14
Stereochemical outcome and kinetic effects of Rp- and Sp-phosphorothioate substitutions at the cleavage site of vaccinia type I DNA topoisomerase. Biochemistry (2000) 1.14
Characterization of mimivirus DNA topoisomerase IB suggests horizontal gene transfer between eukaryal viruses and bacteria. J Virol (2006) 1.07
Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. J Biol Chem (1993) 1.07
Molluscum contagiosum virus topoisomerase: purification, activities, and response to inhibitors. J Virol (1998) 0.95
Ligation of RNA-containing duplexes by vaccinia DNA ligase. Biochemistry (1997) 0.92
Variola virus topoisomerase: DNA cleavage specificity and distribution of sites in Poxvirus genomes. Virology (2007) 0.88
Unmasking Anticooperative DNA-binding interactions of vaccinia DNA topoisomerase I. Biochemistry (2007) 0.86
DNA contacts stimulate catalysis by a poxvirus topoisomerase. J Biol Chem (1999) 0.83
Regulation of catalysis by the smallpox virus topoisomerase. J Biol Chem (2006) 0.82
QIIME allows analysis of high-throughput community sequencing data. Nat Methods (2010) 85.34
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics (2009) 15.93
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest (2008) 9.42
Short pyrosequencing reads suffice for accurate microbial community analysis. Nucleic Acids Res (2007) 9.15
Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell (2008) 8.41
Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol (2004) 8.27
Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol (2011) 7.53
DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res (2007) 6.89
The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog (2008) 5.28
Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol (2010) 4.97
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med (2011) 4.78
HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res (2007) 4.72
Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci U S A (2006) 4.23
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20
Bayesian community-wide culture-independent microbial source tracking. Nat Methods (2011) 3.88
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog (2006) 3.67
Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2010) 3.54
Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol (2002) 3.46
The human gut virome: inter-individual variation and dynamic response to diet. Genome Res (2011) 3.32
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. Sci Transl Med (2012) 3.29
Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature (2013) 3.21
Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol (2006) 3.21
HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog (2011) 2.68
DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res (2008) 2.64
Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One (2010) 2.60
Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A (2013) 2.53
Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med (2012) 2.49
Assessing the potential for AAV vector genotoxicity in a murine model. Blood (2010) 2.48
Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS One (2007) 2.48
Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J Virol (2010) 2.45
Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol (2010) 2.43
Associating microbiome composition with environmental covariates using generalized UniFrac distances. Bioinformatics (2012) 2.19
Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. J Clin Invest (2012) 2.18
The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood (2011) 2.11
The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog (2008) 2.06
Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. Blood (2010) 2.05
HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog (2011) 2.00
Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells. Mol Ther (2009) 1.97
Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol Ther (2005) 1.85
Preferential synapsis of loxP sites drives ordered strand exchange in Cre-loxP site-specific recombination. Nat Chem Biol (2005) 1.77
HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. Mol Ther (2006) 1.75
HIV DNA integration. Cold Spring Harb Perspect Med (2012) 1.73
LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther (2010) 1.72
Inhibition of retroviral pathogenesis by RNA interference. Curr Biol (2002) 1.70
Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer (2011) 1.67
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Retroviral DNA integration--mechanism and consequences. Adv Genet (2005) 1.66
Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One (2013) 1.64
The Gemin6-Gemin7 heterodimer from the survival of motor neurons complex has an Sm protein-like structure. Structure (2005) 1.64
Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV. Blood (2012) 1.64
Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med (2012) 1.64
Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet (2006) 1.62
Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev (2009) 1.62
Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J Virol (2005) 1.61
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature (2013) 1.59
Hypervariable loci in the human gut virome. Proc Natl Acad Sci U S A (2012) 1.58
Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One (2012) 1.51
Roles of host cell factors in circularization of retroviral dna. Virology (2003) 1.51
Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases. PLoS Pathog (2011) 1.50
Structure-constrained sparse canonical correlation analysis with an application to microbiome data analysis. Biostatistics (2012) 1.49
BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Natl Acad Sci U S A (2013) 1.47
HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog (2008) 1.45
Structure of the Y14-Magoh core of the exon junction complex. Curr Biol (2003) 1.43
HIV latency and integration site placement in five cell-based models. Retrovirology (2013) 1.42
A modified γ-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med (2014) 1.42
piggyBac transposase tools for genome engineering. Proc Natl Acad Sci U S A (2013) 1.35
Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics (2012) 1.35
Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency. PLoS Pathog (2012) 1.34
Structural basis for specificity in the poxvirus topoisomerase. Mol Cell (2006) 1.34
A method to sequence and quantify DNA integration for monitoring outcome in gene therapy. Nucleic Acids Res (2011) 1.33
Cre-loxP biochemistry. Methods (2002) 1.31
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum Gene Ther (2006) 1.27
The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep (2013) 1.26
LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs. PLoS Pathog (2012) 1.25
Gammaretroviral integration into nucleosomal target DNA in vivo. J Virol (2011) 1.23
Methods for integration site distribution analyses in animal cell genomes. Methods (2008) 1.21
Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res (2012) 1.21
Tetrameric structure of a serine integrase catalytic domain. Structure (2008) 1.21
A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples. Genome Biol (2012) 1.17
Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile. PLoS One (2012) 1.16
Synapsis of loxP sites by Cre recombinase. J Biol Chem (2007) 1.14
Modeling HIV-1 integrase complexes based on their hydrodynamic properties. Biopolymers (2003) 1.14
Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One (2013) 1.11
Switching between raltegravir resistance pathways analyzed by deep sequencing. AIDS (2011) 1.11
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. PLoS One (2010) 1.07
Role of pICLn in methylation of Sm proteins by PRMT5. J Biol Chem (2009) 1.07
Structural coupling between FKBP12 and buried water. Proteins (2009) 1.07
Solution conformations of prototype foamy virus integrase and its stable synaptic complex with U5 viral DNA. Structure (2012) 1.07
Single-particle image reconstruction of a tetramer of HIV integrase bound to DNA. J Mol Biol (2006) 1.07
Peptide trapping of the Holliday junction intermediate in Cre-loxP site-specific recombination. J Biol Chem (2004) 1.06
Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains. J Biol Chem (2014) 1.04